Latest News Archive

Please select Category, Year, and then Month to display items

UFS celebrates new graduates during December graduation ceremonies

28 November 2023 | Story Valentino Ndaba

General Post, GRADS DEC 2023 — It’s time for the UFS’s December graduation ceremonies!

Esteemed guest speakers

Tirelo Sibisi, Vice-Chairperson of the UFS Council, will be the distinguished guest speaker on the first day of graduations. Sibisi boasts an illustrious career, with over two decades of experience in human resource management, including notable roles at AngloGold Ashanti, the country's biggest cement manufacturer (PPC Cement), IBM, and Telkom. Her contributions extend to various boards and committees, showcasing her expertise and dedication to various fields.

Dr Anchen Laubscher, who also serves on the UFS Council, will take the stage as guest speaker on the second day. Dr Laubscher is currently the Group Medical Director of Netcare Ltd, leading the strategic oversight and operational execution of clinical and quality-related matters. Her commitment to healthcare excellence and leadership, coupled with being the first female President of the UFS Student Representative Council (SRC), exemplifies her remarkable achievements.

Chancellor’s Medallist

Professor Mattheus Lötter is set to finally receive the prestigious Chancellor’s Medal from the Faculty of Health Sciences. This conferral was postponed from the April 2023 graduation ceremonies due to a personal loss experienced by Prof Lötter. This will mark a pivotal point in his distinguished career, allowing him to celebrate a noteworthy accomplishment.

Details of the ceremonies

The festivities are set to commence on 7 December 2023, starting at 09:00 with the graduations for the Faculty of The Humanities, Faculty of Natural and Agricultural Sciences, and the Faculty of Theology and Religion. The day concludes with ceremonies for the Faculty of Education, Faculty of Economic and Management Sciences, and the Faculty of Law, all beginning at 14:30.

The celebration continues on 8 December 2023, at 09:00, as graduands from the Faculty of Health Sciences proudly take the stage.

For further information and updates on the UFS 2023 December graduation ceremonies, click here.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept